Congressional Republicans are scrambling to bar use of a quality-of-life metric, a push Democrats argue could hobble Medicare drug-price negotiations. […]
Mindstrong, once a Silicon Valley darling, is selling off its assets to the therapy platform SonderMind. Former employees told STAT that Mindstrong faced significant pressure from investors to commercialize its… […]
The Biden administration will fine drugmakers that hiked prices faster than the inflation rate on 27 medicines administered in physician offices. […]
Silicon Valley Bank, which does business with roughly half of the nation’s tech and biotech companies, failed on Friday. Now biotech startups are left wondering: Who’s going to finance the… […]
New legislation introduced by Sen. Bernie Sanders would prohibit all insulin manufacturers from charging more than $20 per vial. […]
In Theranos’s backyard, a health tech leader is taking another crack at home blood testing. He wants to make sure the process is bulletproof. […]
It has been more than 11 years since Julia Young was diagnosed with advanced ovarian cancer, and two years since it spread to her lymph system. By her own account,… […]
“There was a lot of pressure to commercialize this way too early,” said Mindstrong co-founder Paul Dagum. […]
Shaw, who took the CEO role in July 2019, was inspired to join Kite in part by the experience of watching her sister fight cancer. […]
In a bid to expand access to pricey cystic fibrosis treatments, a coalition of families and activists is petitioning four governments to make it possible to obtain generic versions of… […]
Copyright © 2022 Biotech Networks, LLC
